The purpose of this study is to determine whether the insulin sensitizing effects of
rosiglitazone were accompanied by changes in 11ß-HSD1 expression and activity in different
tissues. Furthermore the metabolic and hormonal effects of PPAR gamma stimulation by
rosiglitazone will be analysed in several tissues.